Atlas Trials

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Clinical trial NCT04305028 · UNKNOWN

Trial details

NCT number
NCT04305028
Sponsor
Poznan University of Medical Sciences
Status
UNKNOWN
Study type
OBSERVATIONAL
Peripheral Arterial Disease
Start date
2021-03-10
Primary completion
2021-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.